Characterization of Escherichia coli isolates associated with bovine mastitis in Austria

in: Frontiers in Veterinary Science (2026)
Piechl, Susanna M.; Cabal-Rosel, Adriana; Ruppitsch, Werner; Müller, Elke; Braun, Sascha D.; Monecke, Stefan; Ehricht, Ralf; Wehrend, Axel; Urbantke, Verena; Wittek, Thomas; Szostak, Michael P.; Baumgartner, Martina; Loncaric, Igor
Despite advances in dairy husbandry, mastitis-associated Escherichia (E .) coli (MAEC) remains a primary causative agent of bovine mastitis, contributing significantly to economic losses in the cattle industry. This study characterized 50 E. coli isolates from severe, moderate, mild, and subclinical mastitis by antimicrobial susceptibility testing and genotypic analysis, including PCR, DNA microarray, E. coli phylotyping and whole-genome sequencing of selected strains. Antimicrobial resistance rates were highest for ampicillin (30%), tetracycline (20%), amoxicillin-clavulanate (20%), and trimethoprim-sulfamethoxazole (14%); The majority of isolates (66%) was susceptible to antibiotics. One isolate displayed an ESBL phenotype, carrying bla CTX-M-3 and bla TEM-1 genes. Phylogenetic analysis indicated that members of phylogroups B1 (50%) and A (16%) are predominant among the isolates, followed by group C (12%), with the remaining isolates belonging to groups D, E, and F, and two unassigned. The most prevalent virulence-associated genes detected were fimH (100%), and genes of the ferric dicitrate uptake locus ( fecIRABCDE ). Overall, MAEC isolates exhibited diverse and heterogeneous genetic profiles. The proliferation of ESBL-producing E. coli poses a threat within a One Health framework, given the risk of multidrug-resistant strains at the human-animal-environment interface, compromising critical antimicrobials in both veterinary and human medicine.

Third party cookies & scripts

This site uses cookies. For optimal performance, smooth social media and promotional use, it is recommended that you agree to third party cookies and scripts. This may involve sharing information about your use of the third-party social media, advertising and analytics website.
For more information, see privacy policy and imprint.
Which cookies & scripts and the associated processing of your personal data do you agree with?

You can change your preferences anytime by visiting privacy policy.